Mitigating Lactate-Associated Immunosuppression against Intracellular Bacteria Using Thermoresponsive Nanoparticles

Shuya Xiao1, Jundan Yi1, Yueting Zhang1

  • 1School of stomatology, Lanzhou University, Lanzhou 730000, People's Republic of China.

Nano Letters
|April 18, 2023
PubMed

Insights

This study introduces a novel thermoresponsive nanoparticle for treating septic arthritis. The nanoparticle releases vancomycin and oxygen, enhancing the immune response against intracellular bacteria.

Area of Science:

  • Biomaterials Science
  • Immunology
  • Infectious Diseases

Background:

  • Intracellular bacteria cause difficult-to-treat septic arthritis by hiding in macrophages.
  • This sequestration impairs the immune response and antibiotic efficacy due to cell membrane barriers.

Purpose of the Study:

  • To develop a thermoresponsive nanoparticle for enhanced septic arthritis therapy.
  • To investigate the nanoparticle's ability to combat intracellular bacteria and modulate the host immune response.

Main Methods:

  • A thermoresponsive nanoparticle with a fatty acid shell and a calcium peroxide-vancomycin core was synthesized.
  • The nanoparticle releases vancomycin and generates oxygen upon thermal stimulation.
  • The effects on lactate levels, macrophage polarization, and reactive species production were analyzed.

Main Results:

  • The nanoparticle effectively releases vancomycin and produces oxygen.
  • Oxygen generation mitigates immunosuppression by depleting lactate.
  • The treatment enhances M1-like macrophage polarization and increases reactive oxygen and nitrogen species.

Conclusions:

  • The developed nanoparticle offers a dual approach by delivering antibiotics and boosting innate immunity.
  • This strategy shows promise for overcoming the challenges of intracellular bacterial infections in septic arthritis.